So far Pfizer is keeping tight rein on access to the compound, frustrating researchers who say combining drugs might help stave off resistance and expand use to additional groups of patients https://t.co/FSnTqKiJlC— Bloomberg (@business) May 18, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


